Advertisement

Topics

Latest "Pacific Information Exchange, Inc" News Stories

21:08 EST 20th November 2018 | BioPortfolio

Here are the most relevant search results for "Pacific Information Exchange, Inc" found in our extensive news archives from over 250 global news sources.

More Information about Pacific Information Exchange, Inc on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pacific Information Exchange, Inc for you to read. Along with our medical data and news we also list Pacific Information Exchange, Inc Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pacific Information Exchange, Inc Companies for you to search.

Showing "Pacific Information Exchange" News Articles 1–25 of 24,000+

Tuesday 20th November 2018

Bioasis Announces Positive Results from Peripheral Whole-Body PET/CT Scan Study in Non-Human Primates with Lead Investigational Candidate xB3-001TM

xB3-001 demonstrated lymphatic system penetration and more selective tissue distribution with xB3-001 than trastuzumab alone The Company has filed patent applications based on these observations and those data may have broader applicability An updated version of the corporate presentation is available for review at www.bioasis.us/i...


Axelar AB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryAxelar AB Axelar is a drug development company that develops various novel anticancer treatments. The company lead drug candidateAXL1717 is used for the treatmentof nonsmall cell lung cancer. It also offers treatments for disease such as glioblastoma, sarcoma, malignant melanoma and multiple myeloma, and others. Axelar conducts research on inhibitors of insulinlike growth factor1 receptor a...

Dr. Reddy's Laboratories Announces Favorable Outcome in Buprenorphine and Naloxone Sublingual Film Patent Litigation

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) announced today that the United States Court of Appeals for the Federal Circuit issued a decision in favor of Dr. Reddy’s Laboratories Inc., concluding that Indivior had not shown that it is likely to succeed on ...


InVitae Corp NVTA Medical Equipment Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

SummaryInvitae Corp Invitae, formerly Locus Development Inc, is a genetic information company which processes DNAcontaining samples, analyzes information about patientspecific genetic variation and generates test reports for clinicians and their patients. The company's portfolio of diagnostic tests includes preimplantation and carrier screening for inherited disorders, miscarriage analysis, neurol...

PositiveID Corp PSID Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryPositiveID Corp PositiveID, formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products include firefly Dx systems, mband, thermometer, and ENG mobile system. PositiveID's technologies offer re...

Immatics Biotechnologies GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryImmatics Biotechnologies GmbH Immatics is a clinical stage biopharmaceutical company that develops drugs for the treatment of cancer. It develops peptide based active immunotherapy drug candidates based on it novel technology, XPRESIDENT discovery platform. The company has active programs in several tumor types including gastric cancer, nonsmallcell lung cancer and prostate cancer. Its majo...

Advicenne SA ADVIC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryAdvicenne SA Advicenne is a developer of pediatric medicines. The company offers product portfolio such as ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of microtablets for renal tubulopathies. It provides its products for the treatment of neurological diseases and renal disorders in children. Advicen...

HeartSciences Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryHeartSciences, formerly Heart Test Laboratories Inc, is a medical device company that offers cardiac care products. The company develops, manufactures and markets cardiac testing tools for the early detection of heart disease. It offers MyoVista, a screening tool used to determine the presence and level of myocardial abnormalities and the obstruction of coronary arteries. HeartSciences' Myo...

Pfenex Inc PFNX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryPfenex Inc Pfenex is a biologics company that develops biosimilar therapeutics. The company's lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple sclerosis; PF708, a peptide product candidate to treat highrisk fracture patients; and others. Pfenex's pr...

Washington University in St Louis Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryWashington University in St Louis WUSTL, a subsidiary of University of Washington is an educational university which provides education and research services. The university provides various courses of bachelor's, master's, and doctoral degrees in a wide range of traditional and interdisciplinary fields. It provides degree programs in the areas of law, engineering, education, business and i...

Leafy Greens Marketing Agreement and Produce Industry Groups Respond to Protect Consumers in Romaine Outbreak

In light of today’s announcement by government health agencies in the U.S. and Canada of an E. coli outbreak linked to romaine, a group of produce industry associations (listed below) is relying on producers and retail/restaurant customers to support the government health agency advisories and is urging an industry-wide voluntary withdrawal of all romain...

Medical Transcription Billing Corp MTBC Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryMedical Transcription Billing Corp MTBC is a healthcare IT company that offers webbased solutions and related business services. The company offers products such as electronic health records, practice management, patient engagement and mhealth. Its services include offers medical billing, consultancy, medical transcription, business intelligence, document management, and other services. MTB...

Fuse Medical, Inc. Ranked No. 56 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500TM

Fuse Medical, Inc., (OTC: FZMD), (“Fuse” or the “Company”), a contract manufacturer and national distributor of medical devices, announced that it has been named Number 56 on the Deloitte’s 2018 Technology Fast 500TM (“Technology Fast 500TM”), an annual ranking of the fastest growing North American companies in the technology, media, telecomm...

Dexcom and Verily Amend Collaboration and License Agreement

Amendment intended to reinforce joint product development targets, accelerate Dexcom’s efforts in Type 2 diabetes and improve its long-term profitability DexCom, Inc. (

Hunan Fangsheng Pharmaceutical Co Ltd 603998 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryHunan Fangsheng Pharmaceutical Co Ltd Fangsheng Pharma is a researchbased comprehensive pharmaceutical enterprise offers research, development, manufacturing and sales of pharmaceuticals. The enterprise' products include tablets, capsules, granules, oral suspension, powder, suppository, powderinjection, tinctures, sprays, lotions, extracted TCM lotions, small volume injections and bulk phar...

Navitor Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference

Navitor Pharmaceuticals, Inc., a biopharmaceutical company developing innovative therapeutics targeting the activity of mTORC1, or Complex 1 of the mechanistic target of rapamycin, for neurological disorders and chronic diseases of aging, today announced that Thomas E. Hughes, Ph.D., Chief Executive Officer, will present a corporate overview at the 30th An...

Jamieson Wellness Inc. Declares Third Quarter 2018 Dividend

Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX:JWEL) announced today that the board of directors of the Company has declared a cash dividend for the third quarter of 2018 of $0.09 per common share, or approximately $3.4 million in the aggregate. The dividend will be paid on December 14, 2018 to all common shareholders of record at the ...

Inogen Announces Participation in Nasdaq’s 39th London Investor Conference

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in Nasdaq’s 39th Investor Conference in London. Inogen’s President and CEO Scott Wilkinson is scheduled to present on Tuesday, De...

Insulet’s Omnipod DASH™ Insulin Management System Receives ISO 27001 Certification for Information Security

The Only Insulin Pump to Receive Both ISO 27001 and DTSec Certifications Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it has received ISO (International Standards Organization) 27001 certification of it

Healthscope Ltd HSO Financial and Strategic SWOT Analysis Review [Report Updated: 31102018] Prices from USD $125

Healthscope Ltd HSO Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your b...

Cellectar Biosciences Inc CLRB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryCellectar Biosciences Inc Cellectar develops phospholipid drug conjugates PDCs for the treatment and diagnosis of cancer. Its lead product, CLR 131, is a smallmolecule radiotherapeutic PDC, being developed for the treatment of relapse or refractory multiple myeloma. Cellectar's other products in pipeline include CLR 125, CLR 1602PTX, CLR 124 and CLR 1502. The pipeline also includes diagnost...

Palatin Technologies Inc PTN Financial and Strategic SWOT Analysis Review [Report Updated: 26092018] Prices from USD $125

Palatin Technologies Inc PTN Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augme...

OncLive® Presents Its Latest State of the Science Summit™ on Genitourinary Cancers

Summit will feature genitourinary cancer experts OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on genitourinary cancers. The summit will take place on Thursday,...

AmpliPhi Biosciences Corp APHB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAmpliPhi Biosciences Corp AmpliPhi is a biotechnology company which focuses on development and commercialization of bacteriophagebased antibacterial therapeutics. The company by utilizing its proprietary bacteriophage technology developed a pipeline of products for the treatment of various antibioticresistant bacterial infections. Its pipeline product portfolio includes ABSA01 for Staphyloc...

Chiesi USA Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryChiesi USA Inc Chiesi USA, a subsidiary of Chiesi Farmaceutici S.p.A, is a specialty pharmaceutical company. It researches, develops, produces and commercializes therapies in cardiovascular, respiratory, neonatology, rare disease and special care therapeutics. The company's product portfolio comprises Cardene I.V. nicardipine hydrochloride; Curosurf poractant alfa; Zyflo zileuton, Argatroba...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks